🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Parent-Child EF Intervention

RecruitingNAAges 2 Years - 5 YearsAllKoronis Biomedical Technologies
NCT06924307 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Koronis Biomedical Technologies Corporation (KBT) is developing a cognitive intervention to promote healthy development of Executive Function (EF) skills in young children by leveraging a smartphone-based training regime designed for parents.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Children ages 2-5 years. * Caregivers/guardian of the participating child. Exclusion Criteria: * Children with physical disabilities affecting vision, hearing, or basic mobility. * Children with severe developmental delays or disorders * Parents or caregivers who cannot read and understand English
💊

What it tests

  • Executive Function Intervention
📍

Where

2 sites
University of Minnesota, Institute of Child Development
Minneapolis, United States
Mount Sinai General Pediatrics
New York, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy